PropertyValue
?:abstract
  • Hemophagocytic lymphohistocytosis (HLH) is a hyperinflammatory syndrome characterized by fever, hepatosplenomegaly, and pancytopenia. It may be associated with genetic mutations or viral/bacterial infections, most commonly Epstein-Barr virus (EBV) and cytomegalovirus. As for the novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), also known as COVID-19 (coronavirus disease-2019), the cytokine storm it triggers can theoretically lead to syndromes similar to HLH. In this article, we report a case of a 28-year-old female who presented with high-grade fevers, found to have both SARS-CoV-2 and EBV infections, and eventually began to show signs of early HLH. To our knowledge, this is the first case reported in literature that raises the possibility of SARS-CoV-2–related HLH development.
?:creator
?:doi
?:doi
  • 10.1177/2324709620950107
?:journal
  • J_Investig_Med_High_Impact_Case_Rep
?:license
  • cc-by-nc
?:pdf_json_files
  • document_parses/pdf_json/c471c192f7f5480873aeef6439e02bbc6dbec4b2.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7427003.xml.json
?:pmcid
?:pmid
?:pmid
  • 32787459.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Epstein-Barr Virus Versus Novel Coronavirus-Induced Hemophagocytic Lymphohistocytosis: The Uncharted Waters
?:type
?:year
  • 2020-08-12

Metadata

Anon_0  
expand all